Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Motilal Oswal BSE Healthcare ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.36 |
Equity |
99.64 |
|
|
Concentration Analysis |
Top 5 Holdings |
37.93% |
Top 10 Holdings |
55.40% |
Top 25 Holdings |
78.21% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
74.35 |
Healthcare |
25.29 |
Cash |
0.36 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.64 |
PE Ratio |
40.60 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
13.10 |
Max Healthcare Institute Limited |
6.69 |
Cipla Limited |
6.39 |
DIVI LABORATORIES LTD |
6.12 |
Dr Reddys Laboratories Limited |
5.63 |
Apollo Hospitals Enterprise Limited |
5.49 |
Lupin Limited |
3.40 |
Fortis Health Care Ltd |
3.25 |
Torrent Pharmaceuticals Limited |
2.86 |
Laurus Labs Limited |
2.47 |
Glenmark Pharmaceuticals Limited |
2.32 |
Aurobindo Pharma Limited |
2.31 |
Mankind Pharma Limited |
2.08 |
Alkem Laboratories Limited |
1.97 |
Zydus Lifesciences Limited |
1.78 |
Biocon Limited |
1.64 |
IPCA Laboratories Limited |
1.50 |
Cohance Lifesciences Limited |
1.39 |
Krishna Inst of Medical Sciences Ltd. |
1.33 |
Abbott India Limited |
1.28 |
Gland Pharma Limited |
1.19 |
J B Chemicals and Pharma Ltd |
1.04 |
Wockhardt Limited |
1.01 |
Aster DM Healthcare Limited |
0.99 |
Syngene International Limited |
0.98 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|